Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absent, adult, Advicor, Apolipoprotein, assert, asserted, atorvastatin, automatically, Auxillium, awaiting, billion, Boston, Canadian, Cardial, Cardinal, cGMP, Cipher, clarification, construed, court, director, disabled, divestiture, dosage, eighteen, elderly, elevated, embedded, enable, enacted, encapsulation, enjoy, fat, fatty, floating, floor, found, fourteen, Gary, Gray, HDL, identical, impute, incorporated, injunction, knowledge, Kos, largest, lawsuit, LDL, LifeCycle, lipoprotein, LLC, local, Minnesota, monotherapy, mutually, niacin, Niaspan, nonvoting, observer, Omacor, outpatient, overcome, owe, Patou, person, presumption, proxy, PTS, ratably, recommend, reductase, reference, referred, refinanced, refinancing, reply, Republic, resign, revaluation, revalued, reverse, saturated, shipment, shortfall, simvastatin, specialty, split, steady, strict, suspend, suspended, tangible, triglyceride, unannounced, unchanged, unenforceable, Vermont, Virginia, waiting, waive
Removed:
abbreviated, accept, AG, age, ANDA, ANDRODERM, ANDROGEL, Andrology, annually, apnea, article, audience, Bentley, breast, buccal, Bush, Cohen, committed, component, computer, CPD, create, DEA, decline, deformylase, detailing, disorder, dispense, DPT, educate, enforcement, enlargement, expanded, female, fluid, focused, formed, furnish, handling, hormone, hospital, hypogonadal, inEndocrine, inhibitor, inspected, internally, jointly, Journal, laboratory, leading, medical, men, nationally, NDC, opportunity, oral, ordinary, owner, Paddock, partnership, patch, PDF, pentadecalactone, peptide, physician, Political, positive, prescriber, prescribing, procure, promoted, prostate, PTO, published, range, rash, reach, red, refuse, refused, register, retention, revocation, serve, shipping, sleep, Solvay, sought, specifically, sperm, Stephen, suggested, suitable, suppression, team, tentative, theInternational, transdermal, TRT, type, unmet, Watson, wholly, wider, women, young
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Supply, Distribution & Marketing Agreement
- 10.2 Revenue Interest Assignment Agreement
- 10.3 Note Purchase Agreement
- 10.4 Common Stock & Warrant Purchase Agreement
- 10.5 Letter Agreement
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32.1 Section 906 CEO Certification
- 32.2 Section 906 CFO Certification
Related press release
OSCI similar filings
Filing view
External links
Exhibit 10.5
Gary Patou, M.D.
26353 Esperanza Drive
Los Altos, CA 94022
Dear Gary,
As we have discussed, with respect to the Letter Agreement signed by you and the Company dated January 11, 2004 (the “Letter Agreement”), we both agree that the Letter Agreement will continue to govern any consulting services you agree to provide to the Company and that effective July 1, 2006 Section 2(iii) of the Letter Agreement signed is amended to reflect (i) an increase in the hourly consulting rate from $350 to $450 and (ii) $4,000 daily maximum compensation.
Please confirm your agreement with the change by countersigning as provided below.
We look forward to your continued guidance and leadership on the Advisory Committee project team.
Sincerely, |
/s/ Joseph Pane |
Joe Pane |
Vice President |
Human Resources |
AGREED AND ACKNOWLEDGED: |
/s/ Gary Patou |
Gary Patou, M.D. |